SCHEMBL7100533

SCHEMBL7100533

CNN1CCC[C@@H](c2cnc(Br)c(Cl)c2)C1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KCNH2 Q12809 1/20 0.36
CHRNB2 P17787 2/20 0.35
CHRNA4 P43681 2/20 0.35
PROKR1 Q8TCW9 12/20 0.35
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
HRH2 P25021 1/20 0.32
HRH1 P35367 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
DRD2 P14416 1/20 0.32
DRD1 P21728 1/20 0.32
DRD4 P21917 1/20 0.32
DRD5 P21918 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7101551 1.00 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3KCNH2CHRNB2
SCHEMBL7102607 0.96 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3KCNH2CHRNB2
SCHEMBL7102133 0.96 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3KCNH2CHRNB2
SCHEMBL7098864 0.92 CHRNB2 (0.35) SLC6A2SLC6A4SLC6A3KCNH2CHRNB2
SCHEMBL7102124 0.92 CHRNB2 (0.35) SLC6A2SLC6A4SLC6A3KCNH2CHRNB2
SCHEMBL7103819 0.90 CHRNB2 (0.35) SLC6A2SLC6A4SLC6A3KCNH2CHRNB2
SCHEMBL7101259 0.90 CHRNB2 (0.35) SLC6A2SLC6A4SLC6A3KCNH2CHRNB2
SCHEMBL7103451 0.87 PROKR1 (0.38) SLC6A2SLC6A4SLC6A3KCNH2CHRNB2
SCHEMBL7492594 0.87 PROKR1 (0.38) SLC6A2SLC6A4SLC6A3KCNH2CHRNB2
SCHEMBL7101906 0.86 ALDH1A1 (0.39) CHRNB2CHRNA4PROKR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003500402-A 2003-01-07 JP claimed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 EP claimed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 WO claimed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 EP disclosed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 WO disclosed